Pursuant to President Trump’s Executive Order Accelerating Medical Treatments for Serious Mental Illness, the Food and Drug Administration (FDA) and the Health Resources and Services Administration (HRSA) issued requests for information regarding the therapeutic use of psychedelic drugs. Additional information follows. FDA Public Hearing and Request for Comments: The FDA announced a public hearing on the potential future therapeutic use… (Slifer, July 13, 2026) #Mental and Behavioral Health, #Prescription Drugs